The U.S. Food and Drug Administration has approved AbbVie Inc and Danish drugmaker Genmab's blood cancer therapy for adult patients who have received at least two prior lines of treatment, the companies said on Friday.
blood cancer therapy for adult patients who have received at least two prior lines of treatment, the companies said on Friday.
It is the first-of-its-kind therapy to be approved by the FDA for the disease which annually affects 150,000 people globally.glofitamab is under review by the FDA as a treatment for the same set of patients for which Epkinly has been approved.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New FDA guidelines expanding eligibility for those who want to give bloodNew guidelines issued by the Food and Drug Administration are expanding those who are now eligible to donate blood.
Read more »
FDA Advisers Back RSV Vaccine for Pregnant Women That Protects Their NewbornsRSV fills hospitals with wheezing babies each fall and winter, and the virus struck earlier than usual and especially hard in the U.S. this past year.
Read more »
FDA advisers agree maternal RSV vaccine protects infants, but are divided on its safetyA panel of advisers to the U.S. FDA voted unanimously that a vaccine given to pregnant people protects their young infants from severe RSV. But they split on the Pfizer vaccine’s safety with some concerned it may increase rates of premature birth.
Read more »
FDA Panel Backs RSV Vaccine for Moms to Protect BabyA panel of experts voted to approve Pfizer’s new RSV vaccine designed to protect infants from the virus during their most vulnerable first six months of life. Learn more here.
Read more »
FDA advisers vote in favor of RSV vaccine for pregnant peopleFood and Drug Administration advisers voted in favor of a maternal RSV vaccine option from drugmaker Pfizer.
Read more »